Bone Scan Pp

download Bone Scan Pp

of 49

Transcript of Bone Scan Pp

  • 7/31/2019 Bone Scan Pp

    1/49

    Nuclear Medicinein Musculoskeletal system

  • 7/31/2019 Bone Scan Pp

    2/49

  • 7/31/2019 Bone Scan Pp

    3/49

    Introduction

    Nuclear medicine is defined as a medical

    speciality which uses the nuclear properties

    of the matter to investigatephysiology andanatomy, diagnose diseases, and to treat

    with unsealed sources of radionuclide

  • 7/31/2019 Bone Scan Pp

    4/49

    Introduction

    Characteristic:

    Used Radiation from Nuclear desintegration

    Physiologic process and change of function

    from the organbiochemistric process in

    celluler or moleculer levels.

    Non-invasif, sensitivity >>>, specificity

  • 7/31/2019 Bone Scan Pp

    5/49

    Introduction

    A wide variety of musculoskeletal disorders can beinvestigated by nuclear medicine techniques,particularly through Bone scintigraphy/Bone Scan

    The principal conditions that can be imaged are :

    - metastatic bone disease- osteomyelitis

    - variety of benign conditions (fractures,

    avascular necrosis, inflammatories arthro-

    pathies, metabolic bone disease, etc).

  • 7/31/2019 Bone Scan Pp

    6/49

    Bone scan is commonly performed withTc99m-biphosphonates.

    Bone scanning is performed with the

    gamma camera.

    Bone scan is more sensitive thanradiography in detecting skeletal disease.

  • 7/31/2019 Bone Scan Pp

    7/49

    Pathophysiology of Biphosphonate Uptake

    The bone scan provides information that reflectsskeletal metabolic activity.

    The mechanism involved in biphosphonate uptakeis thought by chemiabsorption onto the calcium ofhidroxyapatite in bone, i.e. the biphosphonatemolecule is adsorbed onto the surface of bone.

    The major factors which affect this adsorption :- osteoblastic activity

    - skeletal vascularity.

  • 7/31/2019 Bone Scan Pp

    8/49

    The bone scan therefore reflects the metabolic

    reaction to a disease process.

    Because its ability to detect functional

    change, the bone scan can often be strongly

    positive, well before the structural X-ray

    changes occur.

  • 7/31/2019 Bone Scan Pp

    9/49

    The Normal Bone Scan

    The most important : symmetry.

    There should be uniform uptake, greater activity atsites ofhighest metabolic activity (joint margins)& areas rich in trabecular bone (the spinal

    vertebral bodies).

    Biphosphonate not taken up by the skeleton isexcreted via the urinary tract tracer is

    visualized in kidney & bladder.

    Uptake of bone scanning agents can also occur insoft tissues significant abnormalities.

  • 7/31/2019 Bone Scan Pp

    10/49

  • 7/31/2019 Bone Scan Pp

    11/49

    Three-Phase Bone Scan

    Provide additional valuable info regardingthe vascularity of a lesion.

    This involves :o Initial dynamic flow study (1st phase)

    o A blood pool image (2nd phase)

    o Delayed static images (3rd phase) can beobtained between 2 & 4 hours.

    For the diagnosis ofosteomyelitis, thethree-phase bone scan is typically used.

  • 7/31/2019 Bone Scan Pp

    12/49

  • 7/31/2019 Bone Scan Pp

    13/49

    Bone Scan in Malignancy

    The detection ofmetastatic skeletal diseaseremains the most important indication forperforming a bone scan.

    The common cancers that metastasise to the boneare those of the prostate, breast & lung.

    The most characteristic feature of metastases isirregular focal lesions in a pattern that does notcorrespond to any single anatomical structure.

  • 7/31/2019 Bone Scan Pp

    14/49

    Bone Scan in Malignancy

    In general, metastases must generate anosteoblastic response in order to be detectedon the bone scan.

    Metastases can on occasion produce an areaof decreased uptake (cold lesion) reflectingbone destruction & failure to stimulate ahealing response. This is most often seen inmyeloma or renal carcinoma.

  • 7/31/2019 Bone Scan Pp

    15/49

  • 7/31/2019 Bone Scan Pp

    16/49

    Important variant to recognise : Superscanof malignancyextensive focal lesions.

    Therenal images are not visualizeddue to

    less tracer is excreted via the renal tract.should be followed by more specific

    investigation directed to the site of

    abnormality.

  • 7/31/2019 Bone Scan Pp

    17/49

    Bone Scanning In The Management ofMalignancy

    For staging for a malignancy at presentation.

    Metastases may be present in an asymptomatic

    individual & even in patient with a suspectedmetastasis because of bone pain, moreextensive disease may be found when the bonescan is undertaken.

  • 7/31/2019 Bone Scan Pp

    18/49

    Bone Scanning In The Management of Malignancy

    The bone scan can be helpful in monitoringresponse to therapy. The use of the bonescan to assess the response to therapy is notalways straightforward.

    Flare response : transient worsening of scanfindings in response to treatment in the firstfew months after therapy.

  • 7/31/2019 Bone Scan Pp

    19/49

    Breast Cancer

    An important part ofstaging in breast cancer patients.

    In early breast cancer, the pick-up rate of metastases islow, about 3% in stage II. However, bone scan has a

    useful role as a baseline study In more advances disease, at presentation the pick-up

    rate of metastases is high ( 28%).

    An abnormal bone scan carries a mean survival of 2-3

    years, and is clearly of prognostic importance

  • 7/31/2019 Bone Scan Pp

    20/49

    Prostate Cancer

    Higher incidence of metastases (around 38% ) &increases in more advanced disease good case for

    bone scan in all patients for staging.

    Prostate-specific antigen (PSA) is used to detect

    metastases. Although patients with an elevated PSA

    should have bone scan.

    It is common to find patients with normal PSA but

    who have skeletal metastase.

  • 7/31/2019 Bone Scan Pp

    21/49

  • 7/31/2019 Bone Scan Pp

    22/49

    Lung Cancer

    Most patients with lung cancer have a poor

    prognostic at presentation. The bone scanimportant in such patients where surgery is

    considered to exclude skeletal metastase.

  • 7/31/2019 Bone Scan Pp

    23/49

    Primary Bone Tumours

    A wide variety of benign & malignanttumours can be investigated with bone

    scintigraphy.Of malignant tumours : osteosarcomas,

    Ewings tumours, & giant cell tumoursusually show increased tracer uptakeon both blood pool & delayed images.

  • 7/31/2019 Bone Scan Pp

    24/49

    Primary Bone Tumours

    Among benign tumours, bone scan in most usefulfor detecting osteoid osteoma, as radiographs arecommonly normal & the bone scan has a

    characteristic appearance

    Osteoblastomas & chondroblastomas also showincreased activity on both blood pool & delayedimages but have characteristic X-ray appearances.

  • 7/31/2019 Bone Scan Pp

    25/49

    Osteomyelitis

    The use of bone scan for osteomyelitis has

    become an established routine procedure.

    Uptake in osteomyelitis is usually focal &present in all three phases.

    A bone scan will often show increased

    activity about 2 weeks before an X-raybecomes positive.

  • 7/31/2019 Bone Scan Pp

    26/49

    Metabolic Bone Disease

    Increased uptake in axial skeleton

    Increased uptake in long bones

    Increased uptake in periarticular area Faint or absent kidney images

    Prominent calvaria and mandible

    Beading of costochondral junction

    Tie sternum

  • 7/31/2019 Bone Scan Pp

    27/49

    Avascular Necrosis

    Bony infarction complication offracture

    Bone scanreduced uptake due todiminished blood supply.

  • 7/31/2019 Bone Scan Pp

    28/49

    Imaging infection/inflammation

    Inflammation reaction of the body to any

    kind of injury

    Infection simply means contaminationwith microorganism

  • 7/31/2019 Bone Scan Pp

    29/49

    Radiopharmaceuticals for image infection

    Non specific : Ga-67 citrate

    increased blood supply, vascular

    permeability and enhanced transudation

    Specific : specific processes of accumulation

    comprise a number of possible interaction

    between the radiopharmaceuticals and thetarget

  • 7/31/2019 Bone Scan Pp

    30/49

    Leucocytes : HMPAO, cytokines,

    interleukin-1, 2 and 8, platelet factors 4

    Antibiotics : ciprofloxacin , peptides

    FDG-PET

  • 7/31/2019 Bone Scan Pp

    31/49

    Imaging with Tc99m-Ciprofloxacin(Infecton)

  • 7/31/2019 Bone Scan Pp

    32/49

    Introduction

    Ciprofloxacin is an antibiotic with theproperty of binding to actively dividingbacteria. It binds to the DNA-gyrase

    enzyme.A study showed that it binds to a widerange of bacteria, particularlystaphylococciappropriate for imaginginfection.

  • 7/31/2019 Bone Scan Pp

    33/49

    Introduction

    Imaging is undertaken at 1 hour & 4 hourafter injection. In particular circumstances,

    a 24 hour imaging is essential.

  • 7/31/2019 Bone Scan Pp

    34/49

    Normal Features

    Vascular, renal & urine activity are visible becauseinfecton is renally excreted.

    Decrease of liver,spleen & blood pool activity with time.

    No bone marrow uptake the problem of bone marrow

    interference in the interpretation of inflammatory changdoes not arrise.

    Symmetrical uptake in bone epiphyses in growing

    children is a normal variant.

  • 7/31/2019 Bone Scan Pp

    35/49

  • 7/31/2019 Bone Scan Pp

    36/49

    Clinical Advantages

    The main indication : when there is a need tolocalise the site of bacterial infection, example :in patient with a fever of unknown origin.

    Its particular use in distinguishing activebacterial infectionfrom inflammatory particularlyin orthopaedic conditions : osteomyelitis, septic

    arthritis, evaluation of prostheses, vertebralabscess or infection in the sternum after

    coronary bypass surgery.

  • 7/31/2019 Bone Scan Pp

    37/49

  • 7/31/2019 Bone Scan Pp

    38/49

    In the diabetic foot, is it skin & bone that is

    infected or skin alone ?

    In the knee, is it aseptic inflammation or septicarthritis ?

    In the hip prosthesis, does it have asepticinflammation or is it infected ?

    It aids the management of patients with suspectedor known bacterial infection, particularly with

    regard to key issue of when to stop antibiotictherapy.

  • 7/31/2019 Bone Scan Pp

    39/49

  • 7/31/2019 Bone Scan Pp

    40/49

    Acute Inflammation Vs Active

    Infection

    In typical acute inflammatory joint due to

    rheumatoid or other arthropathy, theuptake at 1 h & 4 h is visible, but at 24 h ithas fadednot infected

  • 7/31/2019 Bone Scan Pp

    41/49

    Acute Inflammation Vs Active Infection

    Infecton is a small molecule which rapidly

    diffuses in & out of sites of inflammation.Itdiffuses in rapidly because of the extrapermeability of an inflammatory lesion. Itdiffuses out because there is no specific

    binding & as the blood level of infectonfalls, so the level in the inflammation willfall.

  • 7/31/2019 Bone Scan Pp

    42/49

    Acute Inflammation Vs Active Infection

    If there is specific binding, then Infecton

    will remain bound to that site because of thedividing bacteria.

  • 7/31/2019 Bone Scan Pp

    43/49

  • 7/31/2019 Bone Scan Pp

    44/49

    As well as its specificity for bacteria, there

    is a dynamic specificity, which helps to

    differentiate active bacterial infection fromacute or active non-bacterial inflammation.

  • 7/31/2019 Bone Scan Pp

    45/49

    The key to the success of this agent is

    not only that it binds to bacteria, but

    that it clears quickly from sites of non-infected inflammation 24 h image is

    essential.

  • 7/31/2019 Bone Scan Pp

    46/49

  • 7/31/2019 Bone Scan Pp

    47/49

  • 7/31/2019 Bone Scan Pp

    48/49

    References

    1. Maisey MN, Britton KE and Collier BD

    (1998). Clinical Nuclear Medicine. 3rd

    edition. Chapman & Hall Medical.London.

  • 7/31/2019 Bone Scan Pp

    49/49